NEW YORK (GenomeWeb News) – NobleGen Biosciences has received a $182,000 Phase I SBIR grant from the National Human Genome Research Institute top optimize chemistry for its Optipore sequencing technology. The Concord, Mass.-based firm is developing a nanopore-based method for DNA sequencing by nanopore induced photon emission (SNIPE).
According to GenomeWeb Daily News sister publication Clinical Sequencing News, NobleGen wants to target clinical sequencing tests with its platform and is confident that it will be able to achieve a turnaround time of less than 24 hours for sequencing and assembling a human genome for "significantly less" than $2,000 in total costs, including labor and IT.
Exiqon said this week that the Roswell Park Cancer Institute in Buffalo, NY will serve as a center of excellence, offering real-time PCR services based on Exiqon's mircury LNA Universal RT microRNA PCR product line.
Waters this week said this week that the University of Minnesota's Mass Spectrometry Laboratory has joined the firm's Centers of Innovation Program. The lab is one of 13 Centers of Innovation named by Waters.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.